Download for Citation Managers
Docetaxel plus cisplatin plus fluorouracil versus carboplatin plus fluorouracil-cetuximab in first-line setting in patients with recurrent or metastatic head and neck squamous cell cancer who did not previously receive neoadjuvant or adjuvant chemotherapy, which is standard?
Mutlu Hasan, Salim Derya Kıvrak, Gündüz Şeyda, Eryılmaz Melek Karakurt, Musri Fatma Yalçın, Coşkun Hasan Şenol
Year : 2017 | Volume: 13 | Issue Number: 3 | Page: 510-513
Click here to read this article